STAT+: Trump’s FDA navigates layoffs, exits, and a new hire

The Trump administration has quietly rehired some of the FDA employees who were previously let go, in a surprising turn of events. Last week, the FDA saw a wave of layoffs that left many employees uncertain about their future. However, sources within the agency have confirmed that some of those employees have now been offered their jobs back.

While the exact number of rehired employees remains unclear, it appears that there have been broad rehirings across various departments within the FDA. For example, a group of twelve individuals who worked in the office responsible for reviewing surgical and infection control devices have all been reinstated. Additionally, employees working on cutting-edge technologies such as digital health and AI-enabled devices have also been rehired.

The rehiring of FDA staff comes amidst a time of uncertainty and confusion within the agency. The sudden layoffs last week sent shockwaves through the FDA and raised questions about the administration’s priorities and decision-making processes. The reinstatement of some employees may provide a sense of relief and stability for those affected by the initial layoffs.

For more details on this developing story, readers can access the full article on STAT+ for a comprehensive overview of the situation. Stay tuned for further updates on the Trump administration’s actions regarding FDA staffing and other related issues.